期刊文献+

肠道病毒71型实验室诊断研究进展

The developments in the diagnosis of the enteroviruses 71
下载PDF
导出
摘要 肠道病毒71型(Enterovirus 71,EV71)为手足口病(Handf,oot and mouth disease,HFMD)和相关疾病的主要病原体,多感染婴幼儿,少数病例可以并发呼吸道感染和心肌炎、无菌性脑膜炎、脑炎、急性弛缓性麻痹等严重疾病,可致残、致死。因此EV71实验室诊断对EV71引起疾病的治疗和防控具有重要意义。本文将从核酸检测、抗体检测及其他检测等三部分对EV71的实验室诊断方法研究进展进行了综述。 Recent outbreaks of human enterovirus 71 ( EV71 ) infection and EV71-associated hand, foot and mouth disease (HFMD) in China have affected millions and potentially lead to life-threatening complications in infants. Furthermore, these outbreaks represent a significant global public health issue in the world. These common infections create a significant burden on our society and heahhcare system. Our understanding of this important group of viral pathogens has increased dramatically in the past decade. The quantitative assay methods for vaccine antigen and neutralizing antibody are the impor- tant research subjects to the development of molecular diagnostic techniques for the detection of the enteroviruses. This re-view discusses recent developments in the diagnosis of the enteroviruses 71.
作者 吴星 梁争论
出处 《微生物学免疫学进展》 2012年第4期58-62,共5页 Progress In Microbiology and Immunology
基金 国家科技支撑项目(2008BAI69B01)资助项目 国家"十一五"重大专项资助项目(2009ZX10004-804)
关键词 肠道病毒71型 诊断 核酸 抗体 Enterovirus 71 Diagnosis Nucleicacid Anti body
  • 相关文献

参考文献34

  • 1Xu F, Yah Q, Wang H, et al. Performance of detecting IgM anti- bodies against enterovirus 71 for early diagnosis [ J]. PLoS One, 2010,5(6) :e11388.
  • 2Liang Z, Mao Q, Gao Q, et al. Establishing China's national stand- ards of antigen content and neutralizing antibody responses for e- valuation of enterovirus 71 (EV71) vaccines[ J]. Vaccine,2011, 29 (52) :9668-9674.
  • 3Oberste M S, Penaranda S, Rogers S L, et al. Comparative evalua- tion of Taqman real-time PCR and semi-nested VP1 PCR for de- tection of enteroviruses in clinical specimens [ J ]. J Clin Virol, 2010,49 ( 1 ) :73-74.
  • 4Palmenbcrg A C. Proteolytic processing of picomaviral polyprotein [ J]. Annu Rev Microbiol, 1990,44:603-623.
  • 5Zhou F, Kong F, Wang B, et al. Molecular characterization of en- terovirus 71 and coxsackievirus A16 using the 5" untranslated re- gion and VP1 region [ J]. J Med Micmbiol,2011,60 (Pt 3 ) :349- 358.
  • 6Perez-Velez C M, Anderson M S, Robinson C C, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis, 2007,45:950-957.
  • 7Nix W A, Oberste M S, Pallansch M A. Sensitive, seminested PCR amplification of VP1 sequences for direct identification of all enterovirus serotypes from original clinical specimens [ J ]. J Clin Mierobio1,2006,44 ( 8 ) : 2698 -2704.
  • 8Singh S, Chow V T, Phoon M C,et aL Direct detection of enterovlr- us 71 ( EV71 ) in clinical specimens from a hand, foot, and mouth disease outbreak in Singapore by reverse transcription-PCR with u- niversal enterovirus and EV71-specific primers [ J ]. J Clin Microbiol,2002,40(8) :2823-2827.
  • 9Brown B A, Kilpatrick D R, Oberste M S, et al. Serotype-specific identification of enterovirus 71 by PCR[ J]. J Clin Virol, 2000, 16 (2) :107-112.
  • 10Tsao K C, Chang P Y, Ning H C, et al. Use of molecular assay in diagnosis of hand, foot and mouth disease caused by enterovirus 71 or coxsackievirus A 16 [ J]. J Viral Methods, 2002,102 ( 1/ 2) :9-14.

二级参考文献33

  • 1Yeo WM, Chow VT. The VP1 structural protein of enterovirus 71 interacts with human ornithine decarboxylase and gene trap ankyrin repeat. Microb Pathog, 2007, 42 (4): 129-137.
  • 2Chen HL, Huang JY, Chu TW, et al. Expression of VPI protein in the milk of transgenic mice: a potential oral vaccine protects against enterovirus 71 infection. Vaccine, 2008, 26 (23): 2882- 2889.
  • 3Luo ST, Chiang PS, Chao AS, et al. Enterovirns 71 maternal antibodies in infants, Taiwan. Emerg Infect Dis, 2009, 15 (4):581- 584.
  • 4Iwai M, Masaki A, Hasegawa S, et al. Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007. Jpn J Infect Dis, 2009, 62 (4): 254-259.
  • 5Zhu SB, Weng KZ, Zhou HW, et al. Severe enterovirus 71-associated hang-foot-and-mouth disease complicated by brainstem encephalitis: report of 2 cases. Chin J Contemporary Pediatrics, 2009, 11 (6): 502-503.
  • 6Li X, Mao C, Ma S, et al. Generation of neutralizing monoclonal antibodies against Enterovirus 71 using synthetic peptides. Biochem Biophys Res Commun, 2009, 390 (4): 1126-1128.
  • 7Wang SM, Liu CC. Enterovirus 71: epidemiology, pathogenesis and management. Expert Rev Anti Infect Ther, 2009, 7 (6): 735-742.
  • 8Ang LW, Koh BK, Chan KP, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore, 2009, 38 !2): 106-112.
  • 9Wu TC, Wang YF, Lee YP, et al. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice. J Virol, 2007,81(19):10310-10315.
  • 10Tung WS, Bakar SA, Sekawi Z, et al.DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet Vaccines Ther, 2007, 5 (6): 1-13.

共引文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部